Medical University of South Carolina

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1955-01-01

Employees: 10K

Market Cap: -

Website: https://www.muschealth.com

Clinical Trials

Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness

Phase 2

Completed

Conditions: Stress Disorders, Post-Traumatic
Schizophrenia

First Posted Date: 2004-03-08

Last Posted Date: 2015-08-10

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 60

Registration Number: NCT00078741

Locations: 🇺🇸
South Carolina Department of Mental Health, Columbia, South Carolina, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)

Phase 1

Terminated

Conditions: Memory, Short-Term

Interventions: Other: matched placebo
Drug: ginkgo biloba

First Posted Date: 2003-10-13

Last Posted Date: 2018-07-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 50

Registration Number: NCT00070954

Locations: 🇺🇸
UMDNJ - NJ Medical School, Newark, New Jersey, United States

Improving Quality of Life for African American Female Adolescents With Lupus

Phase 2

Completed

Conditions: Lupus

Interventions: Behavioral: Educational training
Behavioral: Coping skills and cognitive restructuring techniques

First Posted Date: 2003-09-11

Last Posted Date: 2018-05-09

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 120

Registration Number: NCT00068874

Locations: 🇺🇸
Ronald T. Brown, PhD, Philadelphia, Pennsylvania, United States

Black Pooling Project

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Coronary Disease

First Posted Date: 2003-07-10

Last Posted Date: 2018-05-15

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00064480

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

Phase 2

Completed

Conditions: Osteoporosis

Interventions: Drug: Alendronate

First Posted Date: 2001-02-02

Last Posted Date: 2010-11-07

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 10

Registration Number: NCT00010439

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Markers and Mechanisms of Macrovascular Disease in IDDM

Completed

Conditions: Heart Diseases
Diabetes Mellitus
Diabetes Mellitus, Insulin-dependent
Cardiovascular Diseases
Atherosclerosis

First Posted Date: 2000-05-26

Last Posted Date: 2015-04-14

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 1063

Registration Number: NCT00005474

Behavioral Therapy Plus Naltrexone for Alcoholism

Phase 4

Completed

Conditions: Alcoholism
Alcohol Dependence

First Posted Date: 1999-11-03

Last Posted Date: 2010-10-04

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 160

Registration Number: NCT00000456

Locations: 🇺🇸
Medical Univ. of South Carolina, Charleston, South Carolina, United States

Dose Response Trial of Pergolide for Cocaine Dependence - 1

Phase 3

Completed

Conditions: Cocaine-Related Disorders

First Posted Date: 1999-09-21

Last Posted Date: 2018-05-16

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00000248

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Carbamazepine Treatment of Cocaine Dependence - 1

Phase 2

Completed

Conditions: Substance-Related Disorders
Cocaine-Related Disorders

First Posted Date: 1999-09-21

Last Posted Date: 2017-04-07

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00000242

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy